Labcorp Acquires Toxikon Corporation
November 18, 2021
Labcorp has acquired Toxikon Corporation, a Bedford, Massachusetts-based contract research organization that provides nonclinical in vivo and in vitro testing for pharmaceutical, biotech and medical device clients. The acquisition expands Labcorp Drug Development's nonclinical testing capabilities and creates a strategic Boston-area footprint; Toxikon reported approximately $40 million in annual revenue and the deal closed in December 2021.
- Buyers
- Labcorp
- Targets
- Toxikon Corporation
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Inotiv Acquires HistoTox Labs
April 13, 2021
Healthcare Services
Inotiv, Inc. has entered into an agreement to purchase substantially all assets of HistoTox Labs, a histopathology contract research organization, for $22.0 million in cash. The acquisition (subject to financing and customary closing conditions) expands Inotiv's pathology and histology capabilities, adds a Boulder, Colorado facility with digital pathology and immunohistochemistry capabilities, and is expected to retain all HistoTox employees.
-
ToxStrategies Acquires Clintrex Research Corporation
June 25, 2024
Healthcare Services
ToxStrategies, a Renovus Capital Partners–backed scientific consulting firm based in Katy, Texas, has acquired Clintrex Research Corporation, a Sarasota-based clinical and regulatory development services provider focused on neurodegenerative and CNS therapies. The deal (terms undisclosed) expands ToxStrategies' clinical, regulatory, biostatistics and drug‑development capabilities and is intended to broaden its end‑market reach in the life sciences sector.
-
LabX Media Group Acquires ContractLaboratory.com
November 22, 2022
Professional Services
LabX Media Group acquired ContractLaboratory.com, a B2B laboratory outsourcing and scientific procurement marketplace, to expand its suite of digital offerings for laboratory professionals. The acquisition brings the ContractLaboratory.com marketplace and its founder Pamela Wertalik into LabX’s portfolio to accelerate marketplace growth and better connect labs with companies, governments, and research institutions.
-
US BioTek Laboratories Acquires RealTime Laboratories
March 19, 2024
Healthcare Services
US BioTek Laboratories, a Pike Street Capital portfolio company, has acquired Dallas-based RealTime Laboratories to expand its diagnostic testing capabilities, specifically mycotoxin and infectious disease testing. The deal broadens the combined organization’s services and geographic footprint while both labs continue operating at their respective locations.
-
PharmaLegacy Laboratories Acquires San Diego-Based BTS Research
September 16, 2024
Healthcare Services
PharmaLegacy Laboratories has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO), expanding PharmaLegacy's in vitro and in vivo pharmacology and GLP toxicology capabilities. The acquisition gives PharmaLegacy a local presence in San Diego to increase study capacity and support clients across the United States and North America.
-
Labcorp Acquires Certain BioReference Health Laboratory Assets for $237.5M
March 28, 2024
Healthcare Services
Labcorp will acquire certain laboratory testing businesses and operating assets from Opko Health subsidiary BioReference Health for $237.5 million. The assets — which generate roughly $100 million in annual revenue — include patient service centers and select customer contracts across the U.S. (excluding New York and New Jersey); BioReference Health will retain its oncology and urology diagnostic businesses and full operations in New York and New Jersey. The transaction is expected to close in the second half of 2024, subject to customary conditions and regulatory approvals.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.